Joaquin Saez-Peñataro (Joaquín Sáez-Peñataro)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Multiple Myeloma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Joaquin Saez-Peñataro, Gonzalo Calvo, Juan Bascuas, Maria Mar Mosquera, Maria Ángeles Marcos, Natalia Egri, Ferràn Torres
Association between Reactogenicity and Immunogenicity in a Vaccinated Cohort with Two mRNA SARS-CoV-2 Vaccines at a High-Complexity Reference Hospital: A Post Hoc Analysis on Immunology Aspects of a Prospective Cohort Study. Vaccines 12 (6) (2024)
Marta Garrote, Marta Español-Rego, Aintzane Zabaleta, Verónica González De La Calle, Sergio Navarro-Velázquez, Susana I Inoges, Ascensión López-Díaz de Cerio, Valentín Cabañas, Nieves López-Muñoz, Paula Rodriguez Otero, Juan Luis Reguera, David F Moreno, Nuria Martinez-Cibrian, Lucía López Corral, Lorena Perez-Amill, Beatriz Martin-Antonio, Laura Rosinol, Joan Cid, Natalia Tovar, Joaquin Saez-Peñataro, Miriam Lopez-Parra, Eulalia Olesti, Elena Guillen, Sara Varea, Luis-Gerardo Rodríguez-Lobato, Anthony Matthew Battram, Marta Sonia González, Andrés Sánchez-Salinas, Europa Azucena González-Navarro, Valentín Ortiz-Maldonado, Julio Delgado, Felipe Prosper, Manel Juan, Joaquin Martinez Lopez, José María M Moraleda, Maria-Victoria Mateos-Manteca, Alvaro Urbano-Ispizua, Juan José Lahuerta, Mariona Pascal, Carlos Fernández de Larrea
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Marta Garrote, Marta Español-Rego, Aintzane Zabaleta, Verónica González De La Calle, Sergio Navarro-Velázquez, Susana I Inoges, Ascensión López-Díaz de Cerio, Valentín Cabañas, Nieves López-Muñoz, Paula Rodriguez Otero, Juan Luis Reguera, David F Moreno, Nuria Martinez-Cibrian, Lucía López Corral, Lorena Perez-Amill, Beatriz Martin-Antonio, Laura Rosinol, Joan Cid, Natalia Tovar, Joaquin Saez-Peñataro, Miriam Lopez-Parra, Eulalia Olesti, Elena Guillen, Sara Varea, Luis-Gerardo Rodríguez-Lobato, Anthony Matthew Battram, Marta Sonia González, Andrés Sánchez-Salinas, Europa Azucena González-Navarro, Valentín Ortiz-Maldonado, Julio Delgado, Felipe Prosper, Manel Juan, Joaquin Martinez Lopez, José María M Moraleda, Maria-Victoria Mateos-Manteca, Alvaro Urbano-Ispizua, Juan José Lahuerta, Mariona Pascal, Carlos Fernández de Larrea
Biomarkers of efficacy and safety of the academic BCMA-CART ARI0002h for the treatment of refractory multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Joaquin Saez-Peñataro, Gonzalo Calvo, Juan Bascuas, Maria Mar Mosquera, Maria Ángeles Marcos, Natalia Egri, Ferràn Torres
Association between Reactogenicity and Immunogenicity in a Vaccinated Cohort with Two mRNA SARS-CoV-2 Vaccines at a High-Complexity Reference Hospital: A Post Hoc Analysis on Immunology Aspects of a Prospective Cohort Study. Vaccines 12 (6) (2024)
Joaquin Saez-Peñataro, Gonzalo Calvo, Juan Bascuas, Maria Mar Mosquera, Maria Ángeles Marcos, Natalia Egri, Ferràn Torres
Association between Reactogenicity and Immunogenicity in a Vaccinated Cohort with Two mRNA SARS-CoV-2 Vaccines at a High-Complexity Reference Hospital: A Post Hoc Analysis on Immunology Aspects of a Prospective Cohort Study. Vaccines 12 (6) (2024)
Joaquin Saez-Peñataro, Ferran Torres, Joan Bartra, Juan Bascuas, Anna Vilella, Marta Tortajada, Sebastiana Quesada, Elisenda González, Ester López-Suñé, Antoni Castells, Sandra Serrano, Concepción Camacho, Antoni Trilla, Gonzalo Calvo, null null
Tolerability and Reactogenicity Profile of mRNA SARS-Cov-2 Vaccines from a Mass Vaccination Campaign in a Tertiary Hospital: Between-Vaccine and Between-Population Prospective Observational Study (VigilVacCOVID Study). BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 36 (4) (2022)